US Stock MarketDetailed Quotes

Alnylam Pharmaceuticals (ALNY)

Watchlist
  • 370.000
  • +4.540+1.24%
Close Jan 22 16:00 ET
  • 370.000
  • 0.0000.00%
Post 20:01 ET
48.88BMarket Cap1233.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals (ALNY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
643.84%325.11M
23.82%153.73M
-45.14%-118.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
Net income from continuing operations
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
Operating gains losses
174.35%103.81M
-69.15%17.57M
585.90%58.89M
61.01%173.79M
215.37%70.44M
-21.26%37.84M
97.57%56.93M
-1.74%8.59M
-47.23%107.94M
30.71%22.34M
Depreciation and amortization
-1.28%13.8M
-7.06%13.94M
6.57%14.41M
4.84%56.67M
174.55%14.17M
-40.58%13.98M
-36.01%15M
-48.17%13.52M
21.56%54.05M
-17.33%-19M
Deferred tax
3,534.36%5.6M
2,763.24%9.74M
2,023.13%9.64M
-14,873.63%-106.76M
---107.39M
---163K
--340K
--454K
50.24%-713K
----
Other non cash items
181.42%47.26M
1.14%17.96M
-37.70%15.61M
-15.39%88.15M
180.65%28.54M
-66.82%16.8M
-27.21%17.76M
31.86%25.05M
0.15%104.18M
167.96%10.17M
Change In working capital
-598.92%-204.66M
230.57%50.08M
-100.12%-217.05M
-473.87%-214.08M
-303.20%-108.3M
60.70%41.02M
-159.39%-38.35M
-25.91%-108.46M
651.65%57.26M
80.68%53.29M
-Change in receivables
-978.03%-399.86M
-1,520.26%-136.91M
-1,913.17%-7.43M
1.58%-86.55M
-1,638.07%-59.51M
65.65%-37.09M
424.58%9.64M
-97.86%410K
-92.86%-87.94M
107.26%3.87M
-Change in inventory
-16.02%4.98M
64.03%11.14M
28,150.00%6.22M
-26.01%13.59M
-92.92%849K
23.57%5.93M
242.27%6.79M
105.46%22K
153.81%18.37M
163.18%11.99M
-Change in prepaid assets
-150.60%-20.74M
-89.01%6.78M
56.58%-32.77M
135.76%3.23M
8.05%25.28M
-149.46%-8.28M
321.31%61.69M
-6,010.28%-75.46M
76.55%-9.03M
169.34%23.4M
-Change in payables and accrued expense
167.37%223.51M
144.59%182.15M
-3,101.17%-155.74M
12.68%91.09M
-60.62%-62.11M
-29.60%83.6M
-10.00%74.47M
94.07%-4.87M
-57.85%80.84M
-137.68%-38.67M
-Change in other current liabilities
----
----
----
----
----
-25.78%-14.05M
0.63%-10.95M
-0.10%-12.84M
----
----
-Change in other working capital
-300.64%-12.54M
93.15%-13.08M
4.35%-27.32M
-527.91%-235.45M
-172.42%-12.81M
-112.79%-3.13M
-979.27%-190.94M
-222.75%-28.56M
183.48%55.02M
142.85%17.69M
Cash from discontinued investing activities
Operating cash flow
643.84%325.11M
23.82%153.73M
-45.14%-118.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
Investing cash flow
Cash flow from continuing investing activities
1,756.55%501.11M
-516.56%-141.38M
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
Net PPE purchase and sale
-189.65%-12.14M
-78.26%-14.29M
30.86%-8.97M
44.90%-34.28M
40.60%-9.09M
75.47%-4.19M
49.63%-8.02M
6.61%-12.97M
13.67%-62.21M
29.24%-15.31M
Net investment purchase and sale
7,615.30%515.4M
-402.89%-127.09M
324.60%122.74M
76.55%-63.25M
80.61%-43.7M
-163.70%-6.86M
482.26%41.96M
12.32%-54.65M
-205.93%-269.7M
-89.91%-225.35M
Net other investing changes
----
----
----
-335.26%-19.32M
---117K
----
----
----
66.36%-4.44M
--0
Cash from discontinued investing activities
Investing cash flow
1,756.55%501.11M
-516.56%-141.38M
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
Financing cash flow
Cash flow from continuing financing activities
-536.33%-448.35M
-59.12%53.76M
52.48%44.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
--0
----
Proceeds from stock option exercised by employees
-28.04%77.74M
-38.83%81.22M
90.90%49.37M
105.44%302.95M
17.43%36.28M
335.54%108.04M
168.81%132.78M
-38.97%25.86M
-43.14%147.46M
-45.53%30.89M
Net other financing activities
-553.10%-34.49M
-2,042.36%-27.47M
-273.03%-5.28M
-135.64%-8.79M
-163.37%-5.28M
-163.37%-5.28M
-132.05%-1.28M
-23.70%3.05M
128.16%24.67M
107.50%8.33M
Cash from discontinued financing activities
Financing cash flow
-536.33%-448.35M
-59.12%53.76M
52.48%44.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
Net cash flow
Beginning cash position
14.90%1.12B
49.29%1.02B
18.87%968.65M
-6.18%814.88M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
5.64%868.56M
-3.74%1.04B
Current changes in cash
225.15%377.87M
-77.17%66.11M
132.89%39.54M
381.38%169.01M
49.58%-116.58M
-69.56%116.21M
2,124.43%289.59M
38.76%-120.22M
-211.57%-60.06M
-10.92%-231.22M
Effect of exchange rate changes
-106.14%-927K
981.60%27.51M
241.41%14.06M
-338.44%-15.24M
-258.49%-17.27M
330.36%15.09M
-2,300.00%-3.12M
-556.85%-9.94M
186.02%6.39M
573.07%10.9M
End cash Position
35.40%1.49B
14.90%1.12B
49.29%1.02B
18.87%968.65M
18.87%968.65M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
-6.18%814.88M
Free cash flow
692.02%312.97M
20.06%139.44M
-34.71%-127.28M
-201.54%-42.59M
-130.04%-103.76M
-88.46%39.52M
255.05%116.14M
47.61%-94.49M
106.84%41.95M
70.64%-45.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 643.84%325.11M23.82%153.73M-45.14%-118.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M
Net income from continuing operations 325.05%251.08M-292.43%-66.28M12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M
Operating gains losses 174.35%103.81M-69.15%17.57M585.90%58.89M61.01%173.79M215.37%70.44M-21.26%37.84M97.57%56.93M-1.74%8.59M-47.23%107.94M30.71%22.34M
Depreciation and amortization -1.28%13.8M-7.06%13.94M6.57%14.41M4.84%56.67M174.55%14.17M-40.58%13.98M-36.01%15M-48.17%13.52M21.56%54.05M-17.33%-19M
Deferred tax 3,534.36%5.6M2,763.24%9.74M2,023.13%9.64M-14,873.63%-106.76M---107.39M---163K--340K--454K50.24%-713K----
Other non cash items 181.42%47.26M1.14%17.96M-37.70%15.61M-15.39%88.15M180.65%28.54M-66.82%16.8M-27.21%17.76M31.86%25.05M0.15%104.18M167.96%10.17M
Change In working capital -598.92%-204.66M230.57%50.08M-100.12%-217.05M-473.87%-214.08M-303.20%-108.3M60.70%41.02M-159.39%-38.35M-25.91%-108.46M651.65%57.26M80.68%53.29M
-Change in receivables -978.03%-399.86M-1,520.26%-136.91M-1,913.17%-7.43M1.58%-86.55M-1,638.07%-59.51M65.65%-37.09M424.58%9.64M-97.86%410K-92.86%-87.94M107.26%3.87M
-Change in inventory -16.02%4.98M64.03%11.14M28,150.00%6.22M-26.01%13.59M-92.92%849K23.57%5.93M242.27%6.79M105.46%22K153.81%18.37M163.18%11.99M
-Change in prepaid assets -150.60%-20.74M-89.01%6.78M56.58%-32.77M135.76%3.23M8.05%25.28M-149.46%-8.28M321.31%61.69M-6,010.28%-75.46M76.55%-9.03M169.34%23.4M
-Change in payables and accrued expense 167.37%223.51M144.59%182.15M-3,101.17%-155.74M12.68%91.09M-60.62%-62.11M-29.60%83.6M-10.00%74.47M94.07%-4.87M-57.85%80.84M-137.68%-38.67M
-Change in other current liabilities ---------------------25.78%-14.05M0.63%-10.95M-0.10%-12.84M--------
-Change in other working capital -300.64%-12.54M93.15%-13.08M4.35%-27.32M-527.91%-235.45M-172.42%-12.81M-112.79%-3.13M-979.27%-190.94M-222.75%-28.56M183.48%55.02M142.85%17.69M
Cash from discontinued investing activities
Operating cash flow 643.84%325.11M23.82%153.73M-45.14%-118.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M
Investing cash flow
Cash flow from continuing investing activities 1,756.55%501.11M-516.56%-141.38M268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M
Net PPE purchase and sale -189.65%-12.14M-78.26%-14.29M30.86%-8.97M44.90%-34.28M40.60%-9.09M75.47%-4.19M49.63%-8.02M6.61%-12.97M13.67%-62.21M29.24%-15.31M
Net investment purchase and sale 7,615.30%515.4M-402.89%-127.09M324.60%122.74M76.55%-63.25M80.61%-43.7M-163.70%-6.86M482.26%41.96M12.32%-54.65M-205.93%-269.7M-89.91%-225.35M
Net other investing changes -------------335.26%-19.32M---117K------------66.36%-4.44M--0
Cash from discontinued investing activities
Investing cash flow 1,756.55%501.11M-516.56%-141.38M268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M
Financing cash flow
Cash flow from continuing financing activities -536.33%-448.35M-59.12%53.76M52.48%44.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M
Net issuance payments of debt --------------0--0--------------0----
Proceeds from stock option exercised by employees -28.04%77.74M-38.83%81.22M90.90%49.37M105.44%302.95M17.43%36.28M335.54%108.04M168.81%132.78M-38.97%25.86M-43.14%147.46M-45.53%30.89M
Net other financing activities -553.10%-34.49M-2,042.36%-27.47M-273.03%-5.28M-135.64%-8.79M-163.37%-5.28M-163.37%-5.28M-132.05%-1.28M-23.70%3.05M128.16%24.67M107.50%8.33M
Cash from discontinued financing activities
Financing cash flow -536.33%-448.35M-59.12%53.76M52.48%44.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M
Net cash flow
Beginning cash position 14.90%1.12B49.29%1.02B18.87%968.65M-6.18%814.88M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M5.64%868.56M-3.74%1.04B
Current changes in cash 225.15%377.87M-77.17%66.11M132.89%39.54M381.38%169.01M49.58%-116.58M-69.56%116.21M2,124.43%289.59M38.76%-120.22M-211.57%-60.06M-10.92%-231.22M
Effect of exchange rate changes -106.14%-927K981.60%27.51M241.41%14.06M-338.44%-15.24M-258.49%-17.27M330.36%15.09M-2,300.00%-3.12M-556.85%-9.94M186.02%6.39M573.07%10.9M
End cash Position 35.40%1.49B14.90%1.12B49.29%1.02B18.87%968.65M18.87%968.65M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M-6.18%814.88M
Free cash flow 692.02%312.97M20.06%139.44M-34.71%-127.28M-201.54%-42.59M-130.04%-103.76M-88.46%39.52M255.05%116.14M47.61%-94.49M106.84%41.95M70.64%-45.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -